Data / Drug companies / Lidocaine hci
Lidocaine hci: 7 companies and 21 products in the FDA NDC directory
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Lidocaine hci is listed in the FDA National Drug Code Directory by 7 companies, with 21 products in commercial distribution. 9 of the products (42.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution; liquid; cream, and the newest product started marketing on January 9, 2026.
The request: Get every company that lists lidocaine hci in the FDA NDC directory, with headquarters, website and number of employees. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 7
- Products
- 21
- Generic (ANDA) products
- 9 (42.9%)
- Application numbers
- 11
- Routes
- Topical, Infiltration, Perineural, Epidural, Intracaudal
- Brand names
- Pain Itch Relief, Medi-First Topical Analgesic, HealthWise Roll-On Lidocaine Pain Relief Liquid Lavender Scent, Lidotral 3.88% Roll on, Burn Gel, TheraCare Roll-on Lidocaine Pain Relief Liquid, HealthWise Roll-On Lidocaine Pain Relief Liquid, Electrum Numb Foam
- openFDA record search
- api.fda.gov
Companies that list lidocaine hci
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| HF Acquisition Co LLC, DBA HealthFirst | 10 | injection, solution; injection | Generic drugs (ANDA) | August 7, 2021 |
| Veridian Healthcare | 4 | liquid | Over the counter monograph drugs | September 1, 2025 |
| Trifecta Pharmaceuticals USA LLC | 2 | cream; gel | Over the counter monograph drugs | January 6, 2023 |
| Ultra Distributors Inc | 2 | spray | Over the counter monograph drugs | December 19, 2020 |
| PureTek Corporation | 1 | gel | Other unapproved drugs | February 28, 2024 |
| Renu Laboratories, LLC | 1 | soap | Over the counter monograph drugs | July 29, 2021 |
| Trifluent Pharma, LLC | 1 | cream | Over the counter monograph drugs | January 9, 2026 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 8 | 38.1% |
| Liquid | 4 | 19% |
| Cream | 2 | 9.5% |
| Spray | 2 | 9.5% |
| Gel | 2 | 9.5% |
| Injection | 1 | 4.8% |
| Jelly | 1 | 4.8% |
| Soap | 1 | 4.8% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 10 | 47.6% |
| Generic drugs (ANDA) | 9 | 42.9% |
| New drug applications (NDA) | 1 | 4.8% |
| Other unapproved drugs | 1 | 4.8% |
Pharmacologic classes
| Class | Products |
|---|---|
| Amide Local Anesthetic | 21 |
| Antiarrhythmic | 21 |
| Catecholamine | 1 |
| alpha-Adrenergic Agonist | 1 |
| beta-Adrenergic Agonist | 1 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.